Farr Institute, Swansea University Medical School, Singleton Park, Swansea SA2 8PP, UK; National Centre for Mental Health, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff CF24 4HQ, UK.
Farr Institute, Swansea University Medical School, Singleton Park, Swansea SA2 8PP, UK; National Centre for Mental Health, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff CF24 4HQ, UK.
Schizophr Res. 2018 Sep;199:154-162. doi: 10.1016/j.schres.2018.04.009. Epub 2018 May 2.
Studies assessing premature mortality in people with severe mental illness (SMI) are usually based in one setting, hospital (secondary care inpatients and/or outpatients) or community (primary care). This may lead to ascertainment bias. This study aimed to estimate standardised mortality ratios (SMRs) for all-cause and cause-specific mortality in people with SMI drawn from linked primary and secondary care populations compared to the general population. SMRs were calculated using the indirect method for a United Kingdom population of almost four million between 2004 and 2013. The all-cause SMR was higher in the cohort identified from secondary care hospital admissions (SMR: 2.9; 95% CI: 2.8-3.0) than from primary care (SMR: 2.2; 95% CI: 2.1-2.3) when compared to the general population. The SMR for the combined cohort was 2.6 (95% CI: 2.5-2.6). Cause specific SMRs in the combined cohort were particularly elevated in those with SMI relative to the general population for ill-defined and unknown causes, suicide, substance abuse, Parkinson's disease, accidents, dementia, infections and respiratory disorders (particularly pneumonia), and Alzheimer's disease. Solely hospital admission based studies, which have dominated the literature hitherto, somewhat over-estimate premature mortality in those with SMI. People with SMI are more likely to die by ill-defined and unknown causes, suicide and other less common and often under-reported causes. Comprehensive characterisation of mortality is important to inform policy and practice and to discriminate settings to allow for proportionate interventions to address this health injustice.
评估患有严重精神疾病(SMI)的人过早死亡的研究通常基于一个环境,即医院(二级保健住院患者和/或门诊患者)或社区(初级保健)。这可能导致确定偏倚。本研究旨在比较从初级和二级保健人群中抽取的 SMI 患者与普通人群相比,全因和死因特异性死亡率的标准化死亡率比(SMR)。SMR 使用间接法计算,涉及 2004 年至 2013 年期间英国近 400 万人的人群。与普通人群相比,从二级保健医院入院中确定的队列的全因 SMR 更高(SMR:2.9;95%CI:2.8-3.0),而从初级保健中确定的队列的 SMR 则较低(SMR:2.2;95%CI:2.1-2.3)。与普通人群相比,综合队列的 SMR 为 2.6(95%CI:2.5-2.6)。在综合队列中,SMI 患者的死因特异性 SMR 尤其高于普通人群,原因不明和未知原因、自杀、药物滥用、帕金森病、事故、痴呆、感染和呼吸系统疾病(尤其是肺炎)以及阿尔茨海默病。迄今为止,主要占据文献的仅基于医院入院的研究,对 SMI 患者的过早死亡率估计有些偏高。患有 SMI 的人更有可能死于原因不明和未知的原因、自杀和其他不太常见且经常报告不足的原因。全面描述死亡率对于告知政策和实践以及区分环境以允许采取适当的干预措施来解决这一健康不公问题非常重要。